This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
An ‘Adaptive Treatment Strategy’ for Oral Vancomycin in Patients with the Orphan Disease Primary Sclerosing Cholangitis
Digestive Diseases and Sciences Open Access 19 June 2024
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
Original article
Nakamoto, N. et al. Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis. Nat. Microbiol. https://doi.org/10.1038/s41564-018-0333-1 (2019)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dickson, I. Gut microbiota-mediated liver inflammation in PSC. Nat Rev Gastroenterol Hepatol 16, 140–141 (2019). https://doi.org/10.1038/s41575-019-0116-z
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41575-019-0116-z
This article is cited by
-
An ‘Adaptive Treatment Strategy’ for Oral Vancomycin in Patients with the Orphan Disease Primary Sclerosing Cholangitis
Digestive Diseases and Sciences (2024)